TrialBritish journal of cancer2026

Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer.

Noboru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.